Unknown

Dataset Information

0

The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia.


ABSTRACT: Telomeres and telomerase are closely linked to uncontrolled cellular proliferation, immortalization and carcinogenesis. Telomerase has been largely studied in the context of cancer, including leukemias. Deregulation of human telomerase gene hTERT is a well-established step in leukemia development. B-acute lymphoblastic leukemia (B-ALL) recovery rates exceed 90% in children; however, the relapse rate is around 20% among treated patients, and 10% of these are still incurable. This review highlights the biological and clinical relevance of telomerase for B-ALL and the implications of its canonical and non-canonical action on signaling pathways in the context of disease and treatment. The physiological role of telomerase in lymphocytes makes the study of its biomarker potential a great challenge. Nevertheless, many works have demonstrated that high telomerase activity or hTERT expression, as well as short telomeres, correlate with poor prognosis in B-ALL. Telomerase and related proteins have been proven to be promising pharmacological targets. Likewise, combined therapy with telomerase inhibitors may turn out to be an alternative strategy for B-ALL.

SUBMITTER: da Mota THA 

PROVIDER: S-EPMC10048576 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia.

da Mota Tales Henrique Andrade THA   Camargo Ricardo R   Biojone Estefânia Rodrigues ER   Guimarães Ana Flávia Reis AFR   Pittella-Silva Fabio F   de Oliveira Diêgo Madureira DM  

Genes 20230310 3


Telomeres and telomerase are closely linked to uncontrolled cellular proliferation, immortalization and carcinogenesis. Telomerase has been largely studied in the context of cancer, including leukemias. Deregulation of human telomerase gene <i>hTERT</i> is a well-established step in leukemia development. B-acute lymphoblastic leukemia (B-ALL) recovery rates exceed 90% in children; however, the relapse rate is around 20% among treated patients, and 10% of these are still incurable. This review hi  ...[more]

Similar Datasets

| S-EPMC8268026 | biostudies-literature
| S-EPMC4968601 | biostudies-other
| S-EPMC3232273 | biostudies-literature
| S-EPMC8775816 | biostudies-literature
| S-EPMC4180718 | biostudies-literature
| S-EPMC2784495 | biostudies-literature
| S-EPMC3701905 | biostudies-literature
| S-EPMC7565490 | biostudies-literature
| S-EPMC2762391 | biostudies-literature
| S-EPMC8324476 | biostudies-literature